ResMed to acquire China's Curative Medical
31-Jul-15, Life Scientist
Sleep disorder device supplier ResMed (ASX:RMD) has signed a definitive agreement to acquire its Chinese counterpart Curative Medical. According to ResMed CEO Mick Farrell, the partnership between the two companies will “help many millions of people in China suffering from sleep-disordered breathing and chronic obstructive pulmonary disease”.
%20ResMed.png "ResMed to acquire Chinas Curative Medica (c) ResMed")
Image: ResMed
On completion of the transaction, which is expected to close before the end of 2015, ResMed China and Curative Medical will retain their operational independence and continue to invest in R&D, manufacturing, marketing and sales teams in China.
“By partnering with Curative, we will jointly invest to accelerate our growth while improving patient quality-of-life and reducing total healthcare system costs in China,” Farrell said.